Decreased intraocular pressure in mice following either pharmacological or genetic inhibition of ROCK

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 3, 2009, Pages 187-194

  Whitlock, N Andrew ^a   Harrison, Bryce ^a   Mixon, Travis ^a   Yu, Xiang Qing ^a   Wilson, Alan ^a   Gerhardt, Brenda ^a   Eberhart, Derek E ^a   Abuin, Alejandro ^a   Rice, Dennis S ^a  

^a LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACETAZOLAMIDE; LATANOPROST; PILOCARPINE; RHO KINASE; RHO KINASE 1; RHO KINASE 2; RHO KINASE INHIBITOR; TIMOLOL; UNCLASSIFIED DRUG; Y 39983;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; ARTICLE; CANNULATION; CONTROLLED STUDY; HISTOPATHOLOGY; HOMOLOGOUS RECOMBINATION; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MALE; MOUSE; NONHUMAN;

ACETAZOLAMIDE; ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; AMIDES; ANIMALS; ANTIHYPERTENSIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INTRAOCULAR PRESSURE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCARINIC AGONISTS; PILOCARPINE; PROSTAGLANDINS F, SYNTHETIC; PYRIDINES; RHO-ASSOCIATED KINASES; TIMOLOL;

EID: 66249123108     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2008.0142     Document Type: Article

References (26)

1. Friedman, D.S., Wolfs, R.C., O'Colmain, B.J., et al. Prevalence of open-angle glaucoma among adults in the United States. Arch. Ophthalmol. 122:532-538, 2004.
2. Weinreb, R.N., Toris, C.B., Gabelt, B.T., et al. Effects of prostaglandins on the aqueous humor outf ow pathways. Surv. Ophthalmol. 47(Suppl 1):S53-S64, 2002.
3. Civan, M.M., and Macknight, A.D. The ins and outs of aqueous humour secretion. Exp. Eye Res. 78:625-631, 2004.
4. Reyes, E., Izquierdo, N.J., and Blasini, M. Adverse drugs reactions associated with glaucoma medications. Bol. Asoc. Med. P. R. 89:51-55, 1997.
5. Schwartz, K., and Budenz, D. Current management of glaucoma. Curr. Opin. Ophthalmol. 15:119-126, 2004.
6. Lindsey, J.D., and Weinreb, R.N. Elevated intraocular pressure and transgenic applications in the mouse. J. Glaucoma. 14:318-320, 2005.
7. John, S.W., Anderson, M.G., and Smith, R.S. Mouse genetics: a tool to help unlock the mechanisms of glaucoma. J. Glaucoma. 8:400-412, 1999.
8. Aihara, M., Lindsey, J.D., and Weinreb, R.N. Episcleral venous pressure of mouse eye and effect of body position. Curr. Eye Res. 27:355-362, 2003.
9. Aihara, M., Lindsey, J.D., and Weinreb, R.N. Aqueous humor dynamics in mice. Invest. Ophthalmol. Vis. Sci. 44:5168-5173, 2003.
10. Zhang, D., Vetrivel, L., and Verkman, A.S. Aquaporin deletion in mice reduces intraocular pressure and aqueous fluid production. J. Gen. Physiol. 119:561-569, 2002.
11. Husain, S., Whitlock, N.A., Rice, D.S., et al. Effects of latanoprost on rodent intraocular pressure. Exp. Eye Res. 83:1453-1458, 2006.
12. Bakall, B., McLaughlin, P., Stanton, J.B., et al. Bestrophin-2 is involved in the generation of intraocular pressure. Invest. Ophthalmol. Vis. Sci. 49:1563-1570, 2008.
13. Avila, M.Y., Carre, D.A., Stone, R.A., et al. Reliable measurement of mouse intraocular pressure by a servo-null micropipette system. Invest. Ophthalmol. Vis. Sci. 42:1841-1846, 2001.
14. Aihara, M., Lindsey, J.D., and Weinreb, R.N. Reduction of intraocular pressure in mouse eyes treated with latanoprost. Invest. Ophthalmol. Vis. Sci. 43:146-150, 2002.
15. Aihara, M., Lindsey, J.D., and Weinreb, R.N. Ocular hypertension in mice with a targeted type I collagen mutation. Invest. Ophthalmol. Vis. Sci. 44:1581-1585, 2003.
16. Crowston, J.G., Lindsey, J.D., Morris, C.A., et al. Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice. Invest. Ophthalmol. Vis. Sci. 46:4571-4577, 2005.
17. Crowston, J.G., Lindsey, J.D., Aihara, M., et al. Effect of latanoprost on intraocular pressure in mice lacking the prostaglandin FP receptor. Invest. Ophthalmol. Vis. Sci. 45:3555-3559, 2004.
18. Ota, T., Aihara, M., Saeki, T., et al. The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-def cient mice. Invest. Ophthalmol. Vis. Sci. 47:3395-3399, 2006.
19. Ota, T., Aihara, M., Narumiya, S., et al. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-def cient mice. Invest. Ophthalmol. Vis. Sci. 46:4159-4163, 2005.
20. Honjo, M., Tanihara, H., Inatani, M., et al. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outf ow facility. Invest. Ophthalmol. Vis. Sci. 42:137-144, 2001.
21. Tokushige, H., Inatani, M., Nemoto, S., et al. Effects of topical administration of Y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. Invest. Ophthalmol. Vis. Sci. 48:3216-3222, 2007.
22. Tanihara, H., Inatani, M., Honjo, M., et al. Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers. Arch. Ophthalmol. 126:309-315, 2008.
23. Thieme, H., Nuskovski, M., Nass, J.U., et al. Mediation of calcium-independent contraction in trabecular meshwork through protein kinase C and rho-A. Invest. Ophthalmol. Vis. Sci. 41:4240-4246, 2000.
24. John, S.W., Hagaman, J.R., MacTaggart, T.E., et al. Intraocular pressure in inbred mouse strains. Invest. Ophthalmol. Vis. Sci. 38:249-253, 1997.
25. Rao, V.P., and Epstein, D.L. Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma. Bio Drugs. 21:167-177, 2007.
26. Uehata, M., Ishizaki, T., Satoh, H., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 389:990-994, 1997.